{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoImjsdYLDA","founded_year":2014,"lastupdate":"2021-10-20T00:00:00.000Z","update_date":"2021-10-20T00:00:00.000Z","lastModified":"Oct 20, 2021","confidence_score":56,"active":1,"confidence_score_reason":"not claimed, ","urlname":"kalytera-therapeutics","minimal_profile":null,"status":"Public","fullstatus":"Public on TSX on Jan, 1990;","acquired":0,"description_edited":0,"tag_line_edited":1,"phone":"","registrar":"","biverification":"Yamila Silbert","recentupdates":[{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2024-01-25 07:45:06.000000","last_name":"Levin","first_name":"Eran"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2021-10-20 10:42:21.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2021-10-20 10:50:05.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2021-10-20 10:50:05.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2021-10-20 10:45:44.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2021-10-20 10:45:35.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2021-10-20 10:48:08.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2021-10-20 10:50:14.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2021-10-20 10:48:43.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2021-10-20 10:48:43.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2021-10-20 10:45:38.000000","last_name":"Perlov","first_name":"Maor"},{"email":"genys30@yahoo.com","source":"Manual","datetime":"2018-08-26 19:52:37.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2018-06-14 07:44:37.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2018-06-14 07:43:26.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2018-06-14 07:43:26.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2018-06-14 07:43:26.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2018-06-14 07:43:26.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2018-06-14 07:47:52.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2018-06-14 07:44:47.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2018-06-14 07:46:37.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"genys30@yahoo.com","source":"Manual","datetime":"2018-06-14 08:19:09.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2018-06-14 07:44:25.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:03:01.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:03:01.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-29 11:55:11.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:41:26.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:41:26.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:41:26.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:41:26.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:37:15.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:37:15.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:45:54.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:38:57.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:38:57.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:13:20.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:35:09.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:35:09.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:26:53.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:26:53.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:26:53.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:26:53.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:26:53.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:26:53.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:26:53.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 08:48:36.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:30:44.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:30:44.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:45:02.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 08:48:38.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 08:48:37.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:09:42.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:40:03.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:40:03.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:04:28.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:31:22.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:31:22.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2018-05-02 08:56:25.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 08:48:38.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 08:48:38.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 08:48:38.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 08:48:38.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 08:48:38.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 08:48:38.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 08:48:38.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 08:48:38.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 08:40:57.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 08:40:57.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 08:40:57.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 08:40:57.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:21:56.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"genys30@yahoo.com","source":"Manual","datetime":"2018-08-28 19:25:53.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:39:27.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:39:27.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 08:48:36.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:06:47.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:58:54.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:43:19.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 08:43:58.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 08:58:06.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 08:48:36.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:09:04.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:09:04.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-30 09:14:20.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-29 11:54:41.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-29 11:54:41.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-29 11:54:41.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-29 11:54:41.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-29 11:54:41.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-29 11:54:41.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-04-29 11:54:41.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"katie.mccandless@gmail.com","source":"Manual","datetime":"2019-03-19 14:34:30.000000","last_name":"McCandless","first_name":"Katie"},{"email":"katie.mccandless@gmail.com","source":"Manual","datetime":"2019-03-19 14:34:30.000000","last_name":"McCandless","first_name":"Katie"},{"email":"katie.mccandless@gmail.com","source":"Manual","datetime":"2019-03-19 14:34:30.000000","last_name":"McCandless","first_name":"Katie"},{"email":"katie.mccandless@gmail.com","source":"Manual","datetime":"2019-03-19 14:34:30.000000","last_name":"McCandless","first_name":"Katie"},{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2024-01-25 07:45:06.000000","last_name":"Levin","first_name":"Eran"}],"sectorverify":null,"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgLGr0IIIDA","fullname":"Yamila Silbert"},"biverifydate":"2018-04-29T00:00:00.000Z","crunchbaseid":"kalytera-therapeutics","lastupdator":"Maor Perlov","lastupdator_email":"maorperlov@gmail.com","creator":"Natalia Golczar","creator_email":"ngolczar@gmail.com","createdate":"2018-04-29T00:00:00.000Z","lastupdatedate":"2021-10-20","hide_reason":"7KVi9S7qqUtO0WCsFclwqBEZluejfNYqWC1Uhx0tPHtDxtvxPPaCPH","hide_reason_data":{"reason":"No longer active","visible":0},"logokey":"$sT8o4fqaa80GaSjr1O31OHvbWwBWWktURwebRpBvp3EZeROb584U6s","name":"Kalytera Therapeutics","israeliacquisitions":1,"forbesranking":null,"investmentarm":null,"investmentarmname":null,"hubname":null,"acquired_amount":null,"acquired_by":null,"acquired_country":null,"acquired_month":null,"acquired_year":null,"type":"Multinational","formernames":[],"alternativenames":[""],"country":"United States","inisraelsince":"9/2016","inisraelsincemonth":"9","isisraeli":0,"marketcapital":50912,"marketcapitaldate":"2025-11-01T14:07:38.000Z","oneliner":"Pharmaceuticals","website":"https://kalytera.co","employees":"1-10","employees_exact":6,"employees_overall":"1-500","employees_overall_exact":0,"sociallinks":{"twitter":"https://twitter.com/kalyteraco","youtube":"","facebook":"https://www.facebook.com/kalyteraco","linkedin":"https://www.linkedin.com/company/10554216","instagram":""},"social":["https://www.facebook.com/kalyteraco","https://www.linkedin.com/company/10554216","https://twitter.com/kalyteraco"],"flattenedsociallinks":"https://www.facebook.com/kalyteraco|https://www.linkedin.com/company/10554216|https://twitter.com/kalyteraco","apps":{"appstore":"","googleplay":""},"investmentstage":[],"about":"Kalytera Therapeutics Inc is a clinical-stage pharmaceutical company developing next-generation cannabinoid therapeutics. Kalytera develops novel cannabinoid medicines for a range of medical needs with an initial focus on graft-versus-host disease (GvHD). Kalytera also develops a new class of proprietary cannabidiol (CBD) therapeutics. \r\n\r\nKalytera acquired its GvHD program from Israel-based Talent Biotechs in early 2017 based on the results of Talents' four phase-2a clinical studies in the prevention and treatment of GvHD using CBD.\r\n\r\n","founded":"1/2014","team":[{"name":"David Stefansky","email":"david@kalytera.co","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoIm68K0KDA","bounced":false,"claimed":0,"founder":1,"urlname":"david-stefansky","visible":0,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICgiaOx9ggM","position":"Co-Founder and Chairman of Kalytera's Board of Directors","last_name":"Stefansky","claimtoken":"3b4ba8d8c70d631f6f7d391379758d754a75337149c30011272e019dee9b6adf","first_name":"David","picturekey":null,"claimeddate":null,"linkedinurl":null,"unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":null,"initials":"DS","pictureurl":"/assets/empty-state.svg","linkedin-display":"none","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"private-visibility","visibilityTooltip":"tooltip tooltip-html-content='\n\n
\n \n \n private\n
'"},{"name":"Sari Prutchi Sagiv","email":"saraps8@yahoo.com","phone":"0528594444","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoNnyg48LDA","bounced":false,"claimed":0,"founder":0,"urlname":"saraps8","visible":0,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICg2dvT0woM","position":"Chief Science Officer","last_name":" Prutchi Sagiv","claimtoken":"2dfd82f95555933d9a8b5152206cdf39cedda70a1725dc4ed94f9cf2bb4bee3d","first_name":"Sari","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/sari-prutchi-sagiv-393385/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":null,"initials":"S ","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"private-visibility","visibilityTooltip":"tooltip tooltip-html-content='\n\n
\n \n \n private\n
'"},{"name":"Raphael Mechoulam, Dr.","email":"","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoMmklPQIDA","bounced":false,"claimed":0,"founder":0,"urlname":"raphael-mechoulam-dr","visible":0,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICgyYC5mAgM","position":"","last_name":"Mechoulam, Dr.","claimtoken":"3f2e5f8cf1a585d5e7684594f28798a3813ff701cf17bd5fc4cbbe6b202d6a3f","first_name":"Raphael ","picturekey":null,"claimeddate":null,"linkedinurl":null,"unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":null,"initials":"RM","pictureurl":"/assets/empty-state.svg","linkedin-display":"none","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"private-visibility","visibilityTooltip":"tooltip tooltip-html-content='\n\n
\n \n \n private\n
'"}],"portfolio":[{"name":"TALENT Biotechs","hidden":false,"raised":"Undisclosed","founded":"2014","fullurl":"/company_page/talent-biotechs","logokey":"$kpf3iD5RT6CC41V5zoweMROJbyXEdtV50w5Es621NwPb7SaErCcp8X","urlname":"talent-biotechs","employees":"1-10","company_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwN2azY8KDA","description":"Medical Cannabis Drugs","fundingstage":"Acquired","businessmodel":"B2B","raisedNumber":0,"logourl":"https://storage.googleapis.com/clean-finder-353810/$kpf3iD5RT6CC41V5zoweMROJbyXEdtV50w5Es621NwPb7SaErCcp8X","style":"","hiddenCompanyTooltip":""}],"exits":[],"mediagallery":[],"affiliatedOrganizations":null,"address":{"israeli":[{"id":"288a892a-f5ac-4fca-ae81-5f43e4e19ffc","city":"Qatsrin","type":["R&D"],"address":"Katzrin, Israel ","placeid":null,"notactive":1,"openeddate":"2017-02-01","registrarid":"515518108","firstrdcenter":0,"registrarname":"Kalytera Therapeutics Israel Ltd"}],"officesabroad":null},"headquarter_address":"41 Thunderbird Drive, Novato, CA, USA","news":[{"id":"9ad9d289-2ac9-4e3f-aa18-9121aa402b60","date":"Apr 5, 2021","link":"https://themarketherald.ca/kalytera-therapeutics-inc-completes-name-change-to-claritas-pharmaceuticals-inc-2021-04-05/","source":"themarketherald.ca","visible":1,"analysis":{"tags":"name change","company":"Kalytera Therapeutics Inc.","layoffs":null,"summary":"Kalytera Therapeutics Inc. has changed its name to Claritas Pharmaceuticals, Inc. The company intends to focus on developing its proprietary drug, R-107, for the treatment of vaccine-resistant strains of COVID-19 and other viral infections. The ticker symbol will change to CLAS pending final approval of the TSX Venture Exchange. Shareholders will receive letters of transmittal to exchange their current share certificates for certificates with the new name. The company will hold its annual and special meeting of shareholders on June 17, 2021. Claritas Pharmaceuticals is a clinical-stage biopharmaceutical company.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["name change","focus on R-107","ticker symbol change","annual and special meeting","clinical-stage biopharmaceutical company"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-negative","investment_amount":null,"structured_issues":["Management Changes"],"acquisition_amount":null,"structuredIssuesShow":"#Management Changes","entityGrowthIconPath":"url(/assets/circle-red.svg);"},"sentiment":"growth-negative","analysisId":"pWpNXmIxSE4WANqSouxL6sqySPTM4GkV5ZrNh6LuppkdciPL7tQzYG","news_summary":"Kalytera Therapeutics Inc. (TSXV:KLY) completes name change to Claritas Pharmaceuticals, Inc.","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"fedabacd-a90a-47a9-83c4-905bca42b71c","date":"Nov 4, 2016","link":"http://www.marketwired.com/press-release/santa-maria-petroleum-inc-kalytera-therapeutics-inc-announce-signing-merger-agreement-tsx-venture-smq.h-2173009.htm","source":"www.marketwired.com","visible":1,"analysis":{"tags":"PR, Media Relations","company":"GlobeNewswire","layoffs":"N/A","summary":"The article discusses the services offered by GlobeNewswire, a press release distribution company. It highlights the importance of media relations in PR and offers insights from a PRWeek/Notified survey. GlobeNewswires services include targeted distribution options for sharing news with media, investors, and consumers, a media contacts database, and a PR platform that integrates social listening and media monitoring. The company also partners with various media outlets, including Business Headline, a news publication based in Jaipur, India.","partners":"Business Headline","customers":"N/A","investors":"N/A","confidence":8,"key_topics":"PR strategies, Media Relations, Business News, Media Contacts Database, PR Platform","date_of_event":"N/A","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":"Customers, Partners","acquisition_amount":"N/A","structuredIssuesShow":"#Customers, Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"ksTrO36MMnGMvQ3BZdgSr2On7RcVgB4LXd91yVrH2WjfSZAzeh5KjU","news_summary":"http://www.marketwired.com/press-release/santa-maria-petroleum-inc-kalytera-therapeutics-inc-announce-signing-merger-agreement-tsx-venture-smq.h-2173009.htm","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"ed83fa35-b9af-4c01-82b7-573d82be9077","date":"Sep 23, 2016","link":"http://app.quotemedia.com/data/downloadFiling?webmasterId=101898&ref=11174200&type=HTML&formType=D&formDescription=Official+notice+of+an+offering+of+securities+that+is+made+without+registration+under+the+Securities+Act+in+reliance+on+an+exemption+provided+by+Regulation+D+and+Section+4%286%29+under+the+Act&dateFiled=2016-10-07&cik=1395961","source":"app.quotemedia.com","visible":1,"analysis":{"tags":"Securities Offering","company":"Santa Maria Petroleum Inc.","layoffs":"Not mentioned","summary":"Santa Maria Petroleum Inc. has filed a notice of exempt offering of securities with the United States Securities and Exchange Commission. The company, which is based in Ontario, Canada, has sold securities to the value of $536,314. The offering is not being made in connection with a business combination transaction such as a merger or acquisition. The securities have been sold to nine investors.","partners":"Not mentioned","customers":"Not mentioned","investors":"Not specified","confidence":8,"key_topics":["Securities Offering","Exempt Offering","Equity","Investment","Filing"],"date_of_event":"2016-09-23","valuation_amount":"Not mentioned","impact_on_company":"Neutral","investment_amount":"$536,314","structured_issues":"Investment","acquisition_amount":"Not mentioned","structuredIssuesShow":"#Investment","entityGrowthIconPath":"none;"},"sentiment":"Neutral","analysisId":"ID7CO8W0I3WmlA3h8oV8KgiqKBkCEgSKoSux8DQJzK6ROKGLUu7sYo","news_summary":"Form D filed by SANTA MARIA PETROLEUM INC. on 2016-10-07","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"extensions":null,"events":null,"hide_reasons":[{"id":"75T5aG1f0dpqYFonup40lXNjO046zUH82TaHW1TAiIMf9aYAsSOl0d","reason":"No relevant activity"},{"id":"7KVi9S7qqUtO0WCsFclwqBEZluejfNYqWC1Uhx0tPHtDxtvxPPaCPH","reason":"No longer active"},{"id":"hoyKAmu4YJEHmhtLwCdeFldSnDwaVbPXOnH0RA9hKHCzAcHO6OOrXd","reason":"Pending approval"},{"id":"TC54H7CXyKO8GmPECkbyKJf8n34r70JlfJTJHfo85exRpLaKI1Efs9","reason":"Pending approval - External entity"}],"timeline":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODwuqq8CQw","hub":null,"date":"1990-01-01","batch":"","token":"","amount":null,"hub_id":null,"source":"","ticker":"KALY","enddate":"","mnatype":null,"eventtype":"POEvent","granttype":null,"valuation":null,"investment":[],"hub_logokey":null,"hub_urlname":null,"wasacquired":null,"delistreason":null,"capitalraised":null,"stockexchange":"TSX","eventvisibility":"Public","amountvisibility":null,"duetoacquisition":null,"isextensionround":null,"token_visibility":"","fundingvisibility":null,"stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCI8fW0Cww","acquiredcompany_mna":null,"communitycompany_id":null,"isjointventuregrant":null,"acquiredcompany_spac":"Undisclosed","communitycompany_name":null,"communitycompany_type":null,"stockexchange_logokey":"$1UOE95ayf2fVW0x2l7Lsq8b4M2G7QzKiLXglXZIpQrWJSrOJLDrEEF","acquiredcompany_mna_id":null,"fundingtypefundingtype":null,"acquiredcompany_reverse":null,"acquiredcompany_spac_id":null,"communitycompany_hidden":null,"communitycompany_fullurl":null,"communitycompany_logokey":null,"communitycompany_urlname":null,"acquiredcompany_reverse_id":null,"acquiredcompany_mna_logokey":null,"acquiredcompany_mna_urlname":null,"acquiredcompany_mna_homepage":null,"acquiredcompany_spac_logokey":null,"acquiredcompany_spac_homepage":null,"acquiredcompany_reverse_logokey":null,"acquiredcompany_reverse_urlname":null,"acquiredcompany_reverse_homepage":null,"hub_logourl":"/assets/empty-state.svg","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$1UOE95ayf2fVW0x2l7Lsq8b4M2G7QzKiLXglXZIpQrWJSrOJLDrEEF","communitycompany_logourl":"/assets/empty-state.svg","acquiredcompany_mna_logourl":"/assets/empty-state.svg","acquiredcompany_spac_logourl":"/assets/empty-state.svg","acquiredcompany_reverse_logourl":"/assets/empty-state.svg","style":"","hiddenCompanyTooltip":""}],"techcommunityinvolvement":null,"tags":["natural-active-ingredients","medical-cannabis","pain-relief"],"investments":[],"funds":[],"databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"1-500","fundingtype":"Multinational","parsedName":"Kalytera Therapeutics","logourl":"https://storage.googleapis.com/clean-finder-353810/$sT8o4fqaa80GaSjr1O31OHvbWwBWWktURwebRpBvp3EZeROb584U6s","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$sT8o4fqaa80GaSjr1O31OHvbWwBWWktURwebRpBvp3EZeROb584U6s","teamMembersNumber":3,"nationality":"Foreign","communityinvolvement":[],"popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none"},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}